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81. Introduction 
1.1 MULTIPLE SCLEROSIS 
Multiple sclerosis (MS) is as an autoimmune disease that affects the central nervous 
system. It is progressive, has an unpredictable course and is among the most common 
causes of neurological disability in young and middle-aged adults. More females than 
males are affected by the disease and although disease modifying treatment has been 
available for the last twenty years, there is no curative therapy. 
It was Sir Robert Carswell (1793-1857), a Scottish pathologist, and his French 
colleague Jean Cruveilhier (1791-1874) who independently investigated and 
illustrated the pathology of MS for the first time in 1837. However, it was Jean 
Martin Charcot (1825 - 1893), a neurologist at the Salpêtrière hospital in Paris, who 
described at first the clinical and pathological characteristics of MS. His one-hundred 
and fifty years old definition from 1868 is still used [2].  
1.1.1 Epidemiology and etiology 
The prevalence of MS varies around the world and is highest in northern Europe, 
middle part of North America and southern Australia [3]. In Norway the prevalence 
seems to be increasing and differs from 73.0 per 100.000 population in the northern 
part of the country to 150.8 in the west (Hordaland county, 2003) [4]. The prevalence 
in Hordaland county, Western Norway increased from 20 per 100.000 [5] in 1960 to 
60 per 100.000 in 1983 [6] and finally 150.8 per 100.000 in 2003 [4]. The incidence is 
also increasing, particularly in southern Europe [3]. In Norway, the annual incidence 
stabilized after 1982 at about 6 per 100.000 [4] and there are about 7000 people living 
with MS [7]. The increasing prevalence and incidence are explained by improved 
diagnostic procedures and increased awareness of the disease. The cause of this 
9worldwide variations in prevalence and incidence is not known, but both 
environmental and genetic explanations have been discussed [3]. Approximately 70% 
of people with MS are women, and mean age at onset is between 30 and 40 years [4]. 
The etiology of MS is not known but both genetic and environmental factors seem to 
be involved. There are many genes associated with increased risk for MS, but they 
can not separately explain the cause of the disease [8, 9]. The Epstein-Barr virus is a 
risk factor that is consistently associated with MS and increases the risk with about 10 
times if individuals are infected in childhood and 20 times if they as adults develop 
mononucleosis [10]. Other environmental factors that have been discussed are less 
sunlight exposure, the lack of vitamin D and cigarette smoking [11]. Stressful events 
have been suggested to play a role in the development of MS and may be a factor 
among others that influence the risk of exacerbations [12, 13]. 
1.1.2 Diagnosis  
Patients describe the diagnostic phase as a period of anxious waiting filled with 
uncertainty [14]. In addition, the initial symptoms involve emotional distress [15]. 
The diagnosis is normally decided some time after the first symptoms and is based on 
clinical and laboratory criteria, including MRI, cerebrospinal fluid (CSF) and visual-
evoked response (VER) examinations [7]. Two separate episodes with different 
location in the central nervous system are essential for the diagnosis. Typically, first 
symptoms are sensory disturbances, unilateral optic neuritis, double vision, 
paresthesias of trunk and limb, clumsiness, gait problems and neurogenic bladder and 
bowel symptoms. Many patients also describe fatigue as the first symptom of MS [3].  
In the present study the criteria of Poser et al [16] were used to diagnose the patients 
with definite or probable MS. The Poser criteria, originally made for clinical trials, 
are the most commonly used diagnostic criteria in MS.  
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The Poser criteria define: 
A) Clinically definite MS: 
1. Two attacks and clinical evidence of two separate lesions. 
2. Two attacks, clinical evidence of one lesion and paraclinic evidence of 
another, separate lesion. 
B) Laboratory-supported definite MS: 
1. Two attacks, either clinical or paraclinical evidence of one lesion, and 
cerebrospinal fluid (CSF) oligoclonale bands (OB)/Immunglobulin G 
(IgG). 
2. One attack, clinical evidence of two separate lesions, and CSF OB/IgG. 
3. One attack, clinical evidence of one lesion and paraclinic evidence of 
another, separate lesion, and CSF OB/IgG. 
C) Clinically probable MS: 
1. Two attacks and clinical evidence of one lesion. 
2. One attack and clinical evidence of two separate lesions. 
3. One attack, clinical evidence of one lesion and paraclinic evidence of 
another separate lesion. 
D) Laboratory-supported probable MS: 
1. Two attacks and CSF/BO IgG. 
In 2001 these criteria were replaced by the “McDonald Criteria” by the International 
Panel on the Diagnosis of MS and in 2005 the McDonald criteria were revised to 
clarify definitions, simplify and speed diagnosis [17].  
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1.1.3 Clinical picture 
The clinical course of MS is heterogeneous because several parts of the CNS may be 
involved. In 80-85% of the patients the disease trajectory typically begins with an 
acute episode that evolves over several days, stabilizes and then improves 
spontaneously within weeks. This is the typical onset of relapsing-remitting MS 
(RRMS). The next episode usually occurs rather unpredictably after 1-5 years. 
Gradually the recovery from the relapses are incomplete and symptoms accumulate 
[3, 18]. A small proportion of the RRMS patients may experience a benign type of 
MS with an EDSS score (Kurtzke’s Expanded Disability Status Scale see page 37) of 
3 after 15 years with the disease. In more than two-thirds of the RRMS patients the 
disease develops into a secondary progressive phase (SPMS). In 15-20% of the 
patients MS is progressive from onset, primary progressive MS (PPMS). This patient 
group differs from the RRMS group by a greater relative frequency of males and later 
onset of the disease [19, 20].   
Patients with MS report spasticity and weaknesses, clumsiness and slowness in the 
upper and lower extremities. In addition, patients may have gate and balance 
problems, double vision, instability, dizziness, speech problems and swallowing 
difficulties. 
Patients may also report sensory symptoms like coldness, burning and itching.  
Bowel and bladder dysfunction like constipation or diarrhoea, incontinence, urinary 
urgency, frequency, hesitation and retention seem to be common problems in MS. 
These symptoms may, together with spasticity and reduced sensitivity, also affect the 
patients’ sexual functioning. 
In addition to motor symptoms, patients with MS will often experience fatigue, 
cognitive impairment, neuropsychiatric symptoms, sleep disorders and pain. Fatigue 
is a subjective lack of physical and/or mental energy and is a common disabling 
symptom that frequently leads to disability [21]. As many as 10-20% individuals with 
MS consider fatigue as their most disabling symptom [21].  
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Cognitive impairment in MS is common and occurs in  45-60% of the patients [22]. 
Impairments in complex attention, long-term memory, executive functioning, 
processing speed and information processing are the most common cognitive 
symptoms and affects daily living by reduced ability to run household, maintain 
employment and participate in society [23].  
Neuropsychiatric symptoms including depression, bipolar disorder, euphoria, 
pathological laughing and crying and psychosis are often present and reduce quality 
of life and may be a burden for relatives and friends [24]. Even in the early phase of 
the disease trajectory, these symptoms are common and associated with increased 
disability [25]. Treatments and preventive strategies may reduce these problems and 
should be taken into consideration [18, 26, 27]. These symptoms should be 
recognized and treated appropriately by a multidisciplinary management team [3]. 
Depressive symptoms are the most common neuropsychiatric symptom in MS and 
have a lifetime prevalence of 50% and an annual prevalence of 20%. However, 
methodological difficulties may have influenced these findings. The patient samples 
may not be representative and researchers have not agreed on a ‘gold standard’ for 
diagnosing depression in MS. In addition, the relationship between depressive 
symptoms and cognitive impairment  is not clearly understood and the symptoms are 
overlapping [28]. Depression in MS differs from the classical pattern by more 
symptoms of irritability, discouragement and frustration than the more typical 
symptoms of low self-esteem and feelings of guilt [29]. As impairment increases, the 
risk of depressive symptoms seems to enhance to a modest degree [30] and factors 
like coping styles, hope and uncertainty seem to explain depressive symptoms in MS 
[31]. Patients’ perception of the disease uncertainty and variability and the 
intrusiveness the disease has on daily living are factors associated with depression. In 
addition, changes in social role functioning that are associated with the disease and 
loss of social support are related to depression in MS [32]. Despite the high 
prevalence and the negative influence depressive symptoms have for quality of life in 
MS, they are often not detected or treated [33]. Physicians do not necessarily ask the 
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patients for depressive symptoms and patients may be reluctant to disclose their 
emotional problems. A routine screening for depressive symptoms followed by an 
interview and appropriate treatment is important for patients with MS [34]. 
Psychotherapy, where active coping strategies are enhanced, and antidepressive 
medication are recommended as treatment for depressive symptoms [28]. 
1.1.4 Treatment and prognosis  
Patients with MS are faced with a lifelong chronic disease with a prognostic 
uncertainty and should be well informed about their disease from the beginning. A 
multidisciplinary team should be established with a neurologist, an MS-nurse as a 
coordinator and other health workers depending on the patient’s need for help and 
assessment [3]. There are no curative treatments available for MS. However, to 
improve recovery from relapses corticosteroids are often used although there are no 
evidence for long-term effects of the treatment [3, 7]. To minimize disease activity 
and to prevent progression of disability, disease modifying treatment are introduced 
[7]. Since there are a lack of long-term data to prove the effect of this treatment, 
patients should be informed that they most likely will continue to have relapses and 
become increasingly disabled [3, 18]. Disease modifying treatment should be 
introduced early and each patient needs a careful and continuous follow-up 
concerning treatment response and side effects [7].
Gender, age and initial course of the disease seem to be decisive prognostic factors 
[19, 35]. Female gender, early onset and optic neuritis and sensory symptoms at onset 
have been associated with a better prognosis [36]. In addition, an interval from onset 
to diagnosis exceeding three years seems to be favourable [19]. Patients expect 
information about the prognosis at the time of diagnosis, but this is a difficult task, 
since the disease development is highly unpredictable especially in the early phase of 
the disease. However, it is important to focus on the fact that after 15 years with the 
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disease about 70% of the RRMS patients had no need for walking aid (EDSS  6) and 
nearly 85% had no need for a wheelchair (EDSS  7) [19]. 
1.1.5 MS as chronic disease 
Some people live with chronic diseases like hypertension, diabetes and MS without 
thinking that they are ill. Especially during times when disease symptoms are under 
control of medication or the disease is in a non-active phase, people consider 
themselves as healthy [37]. Most chronic diseases have episodes of exacerbations that 
lead to a shift in perspective from having wellness in the foreground and remove the 
focus from the diseased body to have the disease in the foreground, worrying about 
the strength, duration and consequences of the attack [38]. Another aspect is that 
patients with MS choose to conceal their disease, especially towards working 
colleagues, to maintain their social belonging, preserve control and avoid stigma. On 
the other hand, disclosure of the MS diagnosis is necessary to avoid discrimination 
and to get assistance from others when needed [39].
The individual’s perception of the disease depends on his or hers personal and social 
resources. Patients may find their reaction on receiving the diagnosis more disabling 
than the disease itself and some feel their whole existence threatened. On the other 
hand, patients experience the diagnosis as an explanation to their symptoms and may 
feel relieved [15]. The post diagnostic phase is described as facing the unknown 
where possible loss is an essential experience: loss of health, friends, control, function 
and freedom [40]. Nevertheless, empirical studies show that most patients adapt to 
chronic disease, despite the unstable and unpredictable disease trajectory [41]. 
Patients with mild or moderate MS describe their daily life with the disease as setting 
priorities when time and energy are limited and to change how things have been done 
to make it manageable [42].  
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1.1.6 Disability pension in MS 
At the time of diagnosis, most patients with MS are either full-time workers or 
students. This changes rapidly and those who remain in full-time occupation 
decreases. In cross-sectional studies 50-55% of the patients are disability pensioned 
and with an annual increase of 10-15% [43]. Among MS patients who had recently 
become disability pensioned, 99% mentioned disease related factors as the main 
reason for not being able to continue working. In addition, increased disability 
correlates with decreased employment [44]. Progressive disease course, disability 
problems like mobility and hand function, fatigue, cognitive performance and older 
age are factors associated with disability pension [45].  The workplace’s ability to 
accommodate to the individuals’ need is also decisive for the possibility to continue 
working [46]. MS-patients at risk for disability pension are usually over the age of 39, 
are employed in heavy physical work and have a moderate disability [43]. To remain 
in work is an important value for patients, but only a few receive formal advice 
regarding the possibility to remain in employment. Patients need special attention 
from health personnel on how to cope with the impact disability has on their working 
capacity and employers need information about the disease and advice on how to 
change working environment [44]. 
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1.2 COPING 
1.2.1 Stress and coping 
Life events like loosing a loved one or being diagnosed with a chronic disease or 
disasters like war or tsunami make us aware of how stress situations influence on our 
lives. Daily hassles like time pressure, disliking work and conflicts in the family are 
sources of stress depending on how many hassles are present at the same time and the 
time period they last [47]. Scientists have been concerned with the differences in how 
individuals cope with these situations.  
In the theory, stress has been defined as either response or stimulus. Selye’s response 
perspective focuses on the individual’s reaction to stress and his or hers attempt to 
deal with a demanding situation. Stimuli, however, as described by Holmes and Rahe, 
are events in the environment such as illness or loosing a job, to which a person 
respond. In this stimuli perspective, the research focus is on defining the source of 
stress and is not concerned about the individual’s different reactions to stress [48, 49]. 
Lazarus introduced a third model of stress; as a transaction between the person and 
the environment. This relationship would be the characteristics of a person in relation 
to the nature of the environmental event. He defined stress as a relationship between 
the person and the environment that is appraised by the person as taxing or exceeding 
his or her resources and endangering his or her well-being [49, 50]. Coping strategies 
are mediating factors that are important contributors to reduce stress that may lead to 
health problems and illness [47]. 
Lazarus’ transactional model of stress parallels the modern view of illness, where the 
cause and development of a disease is not only from external organisms but also 
depending on the individual’s ability to cope. Stress is associated with the onset of 
diseases as well as deterioration of symptoms. However, the psychobiological 
mechanisms behind these associations are not fully understood [49]. Nevertheless, 
research is concerned with processes that mediate the relationship between stress and 
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illness. In MS the geographical differences in the incidence of the disease have 
challenged researchers to address factors concerning environment and climate. In 
addition, research in MS has shown that the individual’s experience of stressful life 
events may cause exacerbations.  
Freud’s theory on defence and repression mechanisms to fend off unacceptable ideas 
or feelings is the precursors of the concept of coping. In the 1960s certain defense 
mechanisms were assessed as more adaptive and were labelled coping. Coping was 
conscious strategies used by the individual to react on stressful situations. The first 
generation of coping researchers studied almost exclusively coping reactions to life-
threatening or traumatic life events. Eventually, the attention turned to study a broad 
range of stressful situations [51]. 
According to Kobasa coping theory can be based on the model that personality 
variables mediate stressful events [52], or as Lazarus states that coping is a process in 
the relationship between the person and the environment [50] or finally as Carver 
claims, a combination of the two [53]. Stress and coping could be seen as reciprocals 
to each other; when coping is effective the level of stress is expected to decline and 
when coping is ineffective the level of stress is likely to increase [54]. In 1984 
Lazarus and Folkman published their widely accepted definition on coping describing 
the phenomenon as constantly changing cognitive and behavioral efforts to manage 
specific external and/or internal demands that are appraised as taxing or exceeding the 
resources of the person [50]. The definition is process-oriented and implies a 
distinction between coping and automated adaptive behavior by limiting coping to 
demands that are taxing or exceeding a person's resources. Lazarus and Folkman 
began to stress the importance of studying the situational context in which coping 
took place and described coping as a process [51]. Their approach has three main 
features. First, assessments are concerned with what a person actually thinks or does 
in a stressful situation. Second, what a person actually thinks or does is examined 
within a specific context and third, coping as a process is how thoughts and actions 
change during a stressful event [50]. As an example in MS a person who is informed 
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that he/she has MS could, on the one hand feel relieved because he/she faired a brain 
tumor. On the other hand he/she could feel that the diagnosis threatens important 
values in his/her life and become angry and refuse to talk about it. His/her reaction 
could be quite different if he/she was informed in a room at the hospital with several 
other patients present than if he/she, together with his/her next of kin, were alone with 
the neurologist in his office. Finally, the comprehension of being diagnosed with MS 
may change gradually as knowledge about the disease is achieved. 
1.2.2 Coping functions 
Coping serves primarily problem-focused and emotion-focused functions. The former 
is to obtain information about what to do and mobilize actions for the purpose of 
changing reality. The latter is to regulate emotions tied to the stress situation without 
changing the realities of the situation [50, 54]. Problem-focused coping involves 
strategies like solve, reconceptualize or minimize a stressful encounter. Emotion-
focused coping includes strategies like self-occupation, fantasy, or other conscious 
activities that regulate emotions [51]. Emotion- and problem-focused strategies often 
occur concurrently when the stress situation both have emotional (what cannot be 
changed) and practical (what can be changed) challenges. They can also occur in 
sequences. For instance, after getting diagnosed with a chronic disease a period of 
denial or minimalization often occurs immediately. This is gradually replaced by 
problem-focused concerns concentrating on treatment programs and getting on with 
one's life [50]. Support for the existence of the two functions in coping comes from 
anecdotal accounts and empirical research and the two functions can both impede and 
facilitate each other [50].  
Another basic dimension of coping is avoidance-oriented coping, such as denial and 
withdrawal [51]. The research on how avoidance coping influence adaption is mixed 
and the common apprehension is that avoidance hinders adaption. Several studies 
have shown that avoidance coping is associated with poorer adjustment to chronic 
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diseases, and with depression and distress [55]. However, to cope with a short-term 
stressor like myocardial infarction, avoidance coping may be effective and gives the 
person an opportunity to escape [56]. In the later stages of the disease it is important 
to move from avoidance to more problem-focused coping strategies to enhance 
adaptation [41]. Patients with MS tend to employ more emotion-focused and 
avoidance strategies when there is a likelihood of recurrence of the disease [41]. 
The characteristics of the stress situation will determine which coping strategies that 
are the most adaptive. If the stressor is appraised as changeable, problem-focused 
coping is preferred and will effectively reduce the stressor. Patients, when diagnosed 
with MS, who actively approach both emotional reactions like threat and fear and 
seek information and knowledge will probably experience the disease as more 
controllable. On the other hand, patients with MS who appraise the situation as 
uncontrollable where little can be done employ emotion-focused or avoidance 
strategies and may as a result develop helplessness and depression. 
1.2.3 Coping as a style 
Carver et al state that coping may be viewed as a style influenced by individual 
differences in two ways. First, the apprehension is that people have a set of coping 
styles that they employ in stressful situations. They do not approach each stress 
situation as new but rather handle the situation by using a preferred set of coping 
strategies that are stable across different stress situations [53]. However, according to 
Lazarus and Folkman assessing coping as a style impedes the possibility to study a 
person’s freedom and flexibility to alter coping strategies in changing circumstances 
and locks him/her into a certain pattern of responding [50]. Second, it is reasonable to 
think that dimensions of the personality, like consistent patterns of thoughts, feelings 
and actions affect coping behavior and interact with the environment to shape the 
appraisal of the stress situation. Further, personality dimensions like optimism and 
pessimism are expected to employ respectively active coping and emotional distress 
20
and disengagement. In addition, self-esteem seems decisive for the choice of coping 
strategies. People high in self-esteem choose more active coping strategies. Similarly, 
people who have the need to be in control of the situation, are more engaged in 
planning and active coping than those who believe that the consequences of one’s 
behavior  are not under one’s own control [48, 53]. Finally, personality traits are 
linked to coping behavior e.g. the personality trait neuroticism (vulnerable to life 
stress) facilitates anxiety and depression, and it is reasonable to assume that this will 
affect coping behavior [57].  
1.2.4 Coping as a process 
The coping process describes what a person thinks or does in a specific situation and 
the changes in the thoughts and actions that occur across events or as the event 
unfolds. There are three main features in a coping process. First, the focus is on what 
the person actually does and not what they usually do. Second, what they think and do 
is examined within a specific context. Third, the process perspective is concerned 
with the change in coping thoughts and acts and how the individual employ the most 
suitable coping strategies for the situation. The coping process is dynamic and a 
subject of continuous appraisals and reappraisals as the person-environment 
relationship is shifting. Adaption to living with a chronic disease is an example of a 
coping process, starting with shock and disbelief that involves denial and 
disengagement, then feelings of threat and loss until there finally is an acceptance for 
the disease as a part of one’s life [50]. Exacerbations of the disease may lead to a 
restart of the coping process.  
To measure coping as a process is to assess coping strategies that are responding to a 
specific stressful situation e.g. being diagnosed with MS. A way of assessing this 
perspective is to ask for coping strategies from a variety of situations. Respondents 
are then asked to think about a recent stressful event and respond to the coping items 
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of an instrument designed for this purpose [51]. Critics of this approach have 
questioned how accurate respondents recall such stress situations [57].  
If health personnel did not believe in coping as a process that can change and become 
more appropriate, their role in guiding people to a better life with a chronic disease 
would be limited. At the same time it is of great importance to be able to combine the 
two perspectives and know something about the personality of a patient; an essential 
condition for building a good relationship that again will help the patient to a better 
life with the disease. Personality or personal dispositions will interact and shape the 
perceptions of a stress situation. These consistent patterns of thoughts, feelings and 
actions seem to occur under routine conditions. However, it has also been stated that 
personal dispositions are best exposed under stress [57]. In the research by Carver et 
al these consistent patterns and the situational coping are combined [53] and 
hopefully patients with MS will choose between a variety of styles to cope with their 
disease. 
1.2.5 Appraisal 
A central concept in Lazarus' and Folkman's coping theory is appraisal that refers to a 
cognitive process that evaluates what is happening and shapes the emotional and 
behavioral response [50]. Appraisal includes the so-called primary and secondary 
appraisal. Primary appraisal is the process of deciding whether what is happening is 
relevant to one's values, beliefs about self and the world and situational intentions 
and, if so, in what way. If the reverse is the case, and the result of primary appraisal is 
that the event is not relevant to one's well being, there is nothing further to be 
considered [54]. If the interpretation of the situation is positive i.e. as a challenge, 
positive emotions will occur. On the other hand, if the situation is appraised as 
negative i.e. as a threat or a loss, negative emotions like anxiety, anger or grief will 
occur [41]. A young mother with small children who is diagnosed with MS will 
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appraise the situation as a threat to most of her values and beliefs about being a young 
woman and a good mother.  
Secondary appraisal is the process of focusing on what can be done; what coping 
options are available and what constrains are against acting them out. Do I need to 
act? What can be done? Which option is the best? [54]. The individual’s appraisal 
decides which coping strategies that are suitable to handle the situation. For the young 
mother with MS, she may have to reduce or leave her job in order to have enough 
energy to take care of her small children. Secondary appraisal never operates 
independently of primary appraising.  
A third step in the appraisal process is reappraisal, where an evaluation of primary 
and secondary appraisal on the basis of new information takes place. The individual 
may appraise what initially was a threat as a challenge and may reconsider the choice 
of coping strategy. Knowledge about the disease may stimulate patients with MS to 
reconsider and seek alternative actions to handle disease related problems. 
1.2.6 Factors that influence coping in MS 
Several factors influence appraisal and coping. Internal factors like personality and 
external factors like characteristics of the situation shape the individual’s coping 
behavior. To understand coping in patients with MS it is important to address some 
internal and external factors that might influence their coping ability. 
1.2.6.1 Uncertainty 
Uncertainty is known to be very stressful and coping strategies needed for an event’s 
occurrence are different from the strategies needed for an event that is uncertain 
whether it will occur or not [50]. Patients with MS may experience high levels of 
illness uncertainty [58] that will have an influence on their coping ability. The Mishel 
23
Uncertainty in Illness Scale describes four key factors: ambiguity concerning the state 
of the illness, complexity regarding treatment and the health care system, lack of 
information about the diagnosis or severity of the illness, and the unpredictability of 
the disease course and prognosis [59]. Adaption to chronic illness depends upon the 
appraisal of uncertainty. If uncertainty is appraised as danger and the outcome will be 
harmful, coping strategies will aim at reducing uncertainty by collecting information 
and knowledge or by avoiding the situation. On the other hand, if the uncertainty is 
appraised as an opportunity with a positive outcome, i.e. not knowing when the next 
attack of a disease occurs gives an opportunity to think that it will not occur; coping 
strategies that maintain the uncertainty will be applied. In their stress and coping 
model, Lazarus and Folkman also describe the adaption to illness uncertainty as either 
appraised as a danger or as an opportunity [50]. In MS as in other chronic illnesses 
high levels of illness uncertainty was related to less hope, more illness intrusiveness, 
greater emotional distress and mood disturbances such as anxiety, tension, anger and 
depression. In addition, interventions to reduce illness uncertainty were associated 
with higher self-efficacy, less psychological distress and greater life satisfaction [59]. 
In our culture and in the health care system, predictability and control are major 
values and there are little room for chance and uncertainty. Nevertheless, people who 
live with a chronic disease have to accept that uncertainty is their new rhythm of life 
and certainty and predictability is limited. Health providers who focus on 
predictability and certainty will block or prolong the process of adapting to 
uncertainty [60].  
Lack of information may enhance uncertainty.  Knowledge about the actual chronic 
disease develops over time and those most recently diagnosed demonstrate higher 
levels of illness uncertainty and have a higher need for information.  Information and 
knowledge may reduce the degree of unpredictability and strengthen coping efforts.  
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1.2.6.2 Person factors 
As already mentioned person factors influence coping and Lazarus points out two 
person characteristics as important: commitments and beliefs. Commitments reflect 
what is meaningful and important to a person and determine the effort a person is 
willing to invest to remove what may threaten that commitment. Patients with MS 
may have a strong will to continue a normal life through commitments like family, 
friends and job. Beliefs are personally and culturally shaped and have an influence on 
a person’s vulnerability or resistance to stress situations. Control or loss of control is 
basic concepts in this person characteristic. The feeling of control for patients with 
MS can be decisive for the degree of helplessness [48, 50]. 
1.2.6.3 Social support 
Social support encompasses both personality, personal relationships and social 
networks and it is interesting to study how the three perspectives influence the 
individuals’ effort to cope with life events [61].The importance of social support in 
adjustment to illness is well known, but it is less known how social support actually 
works [50]. Social support can be conceptualized in three different ways: 
- perceived social support is defined as the comprehension that others are 
available and willing to help when needed 
- supportive relationship is social bonds that provide the individual with help in 
coping with a situation 
- supportive network are people with personal links who provide support to the 
individual [50, 61]. 
We assume that social support helps to prevent stress and to make threatening 
situations less harmful. In addition, support from others can provide valuable 
information for coping when a difficult situation occurs [50]. MS studies have shown 
relationships between high perceived social support and better adjustment to the 
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disease. However, supporters who are over-solicitous and critical are unhelpful in 
adaption to MS [62]. We can distinguish between emotional support and 
informational support. Carver et al describe these coping responses as seeking social 
support for emotional reason or for instrumental reason. The first is to get moral 
support, sympathy and understanding and the latter is seeking advice, information or 
assistance [53]. 
1.2.6.4 Informational social support 
Many patients with MS start their information-seeking in the prediagnostic phase and 
continue until the diagnosis is confirmed. They seek information from health 
personnel, popular literature, medical text, family and friends [63]. People seek 
information when they become ill because the gap in their knowledge prevents them 
from sense-making in this new situation. Information can be used as an emotion-
focused strategy to support a decision already made or as a problem-focused strategy 
to decide what has to be done. If a patient does not seek information about their 
illness, health personnel should be asking why. Some MS patients seek information to 
be prepared for how bad the disease can become and to stay in control over the 
situation, others will avoid information because they find it pushing them into a 
danger they cannot avoid and will wait to seek information until they know they can 
cope with the stress the information provoke [64]. 
Being diagnosed with MS has been spoken of as a phase of uncertainty, variability 
and unpredictability. The diagnostic phase is time consuming and a source of  ‘fearing 
the worst’[40] and after being told that they have an incurable disease, patients have 
been told to ‘go away and live with it’[65]. Some patients experienced a sense of 
relief, because ‘fear of the worst’ could be put aside but for many patients the 
diagnosis was a source of severe stress and involved a range of emotional reactions. 
In addition, it is the patients’ perception of the diagnostic phase, rather than what 
actually happened that influence the way they approach the future and their 
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relationship with the health care team [65]. The importance of patient information to 
gain control, reduce anxiety, create realistic expectations, promote self-care and 
participation and stimulate feelings of safety is considered as an important need for 
people who face a chronic disease. Patients with MS ask for more such supportive 
follow-up after the diagnosis. 
1.2.7 Coping with chronic disease 
Chronic disease is without the prospect of recovery and usually with a relatively long 
duration. Patients are required to live with the limitations the disease imposes on their 
life. There are vast differences in cause, course and final outcome both among the 
different diseases and within the same disease. Most of the chronic diseases have 
episodes of exacerbations that accumulate the disease progression. 
A chronic disease confronts patients with threats and challenges like preserving a 
reasonable emotional balance and self-image, maintaining competence and mastery, 
sustaining relationships with family and friends and preparing for an uncertain future. 
In addition, diagnostic uncertainties, disability, dependency and life-style changes 
disrupt valued activities [66]. Despite severe chronic conditions, empirical studies 
show that most patients adapt to chronic disease [41] and the difference in health 
related quality of life between patients with some chronic diseases and normal 
controls is less pronounced than expected [67]. 
Avoidant, emotion-focused strategies have been related to poorer adjustment to 
chronic disease, whereas problem-focused strategies have been related to a more 
sufficient adjustment. These findings may however, be oversimplified as studies have 
shown that passive coping also has been positively related to adjustment in groups of 
chronically ill patients. In addition, characteristics of the disease and the treatment 
have an impact on the appraisal of the situation and together with the complexity of 
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the coping process and the variety of possible outcomes the association between 
coping and adaption may be weak [41].  
Social stigma, described as the undesired differentness, has been associated with 
chronic diseases. A person, who fails to perform as expected, will change her 
definition of self and become discredited. Coping is described as a bargaining process 
for managing stigma and the individual try to control the body and the environment to 
communicate social status and identity. Further, to avoid social stigma, persons with a 
chronic disease may be engaged in developing a way of coping with the disease and 
health personnel should pay special attention to the under- or overemphasizing of the 
disease to obtain a balance between treating a chronically ill as normal and yet 
acknowledge the disease [39]. 
1.2.8 Research on coping in patients with MS  
The majority of coping research in MS is based on Lazarus and Folkman’s theory and 
their instrument “The Ways of Coping Checklist”. A tendency through these studies is 
that the positive relationship between problem-focused coping and adaption is less 
clear in MS than in chronic diseases in general. However, as in research on coping 
with chronic disease in general, passive, avoidant-focused strategies are related to 
poorer adaption [32]. 
A search in PubMed, Ovid Nursing and PsychInfo in July 2009 on the terms ‘multiple 
sclerosis’ and ‘coping’ showed a large number of papers. Thirty-seven of these 
assessed the relationship between coping strategies and different other variables and 
were considered applicable for presenting data on coping with MS. These other 
variables included depression, anxiety, social support and quality of life. These 
studies could be classified into three categories:  Cross-sectional studies comparing 
groups and factors influencing coping, longitudinal studies comparing groups and 
factors influencing coping and studies on different interventions using coping as 
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outcome measure (Table 1). Thirteen different coping scales were applied, 12 were 
generic questionnaires and one was MS specific. Twenty-three studies have evaluated 
factors that may influence coping and 10 of these studies have compared coping 
among various groups, 11 studies were longitudinal with a follow-up time that varied 
from 3 months to 3 years, two studies measured coping as a result of an intervention 
and 3 studies measured coping as a part of a medical trial. 
Number of participants with MS varied from 20 to 502 and 2 studies had only female 
participants. Seven studies compared MS-patients with normal controls and 3 studies 
compared them with other patient groups. Participants were recruited from one clinic 
or area or from the local MS Society or both and were a cross section of patients with 
MS in the study area. Only one study had included patients who were newly 
diagnosed with MS (<2years). 
These studies showed a strong and consistent relationship between certain emotion-
focused strategies (wishful thinking and avoidance coping) and poorer adjustment to 
MS. In addition, although not so strong, there is a relationship between problem-
focused coping (seeking social support) and better adjustment. Patients with higher 
levels of psychological distress and in exacerbation employed more emotion-focused 
coping. Furthermore, patients were less likely to employ problem-focused coping 
strategies compared to normal controls. However, the assumption that coping is a 
predictor of adjustment is more complex; some demonstrated that coping predicts 
adjustment to MS and some, although fewer, did not.  
Depression in patients seems to enhance emotion-focused and avoidance coping and 
patients who employ these strategies seem to be more depressed. However, this 
relationship is problematic because of the conceptual overlap. Furthermore, problem-
focused or active strategies are associated with better quality of life. Teaching coping 
skills in group-therapy seems to improve coping ability over time. 
The presented studies have some methodological limitations. These are the variety in 
sample sizes, coping instruments employed and variables that are controlled for. In 
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addition, the differences in adjustment outcomes and in the context of the stressors 
participants are asked to describe. These differences may explain differences in the 
results [62]. 
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Table 1. Previous studies on MS and coping.
I Cross-sectional studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
Warren S 
1991 [68] 
Emotional stress and coping 
in MS exacerbations. 
95 WCC Patients in exacerbation favored 
emotion-focused coping. 
Buelow JM 
1991 [69] 
A correlational study of 
disabilities, stressors and 
coping methods in victims 
of MS. 
20 Jalowiec 
Coping 
Scale 
Positive correlation between future 
uncertainty and fatalistic coping and 
negative correlation between 
depression and optimistic coping. 
O’Brien MT 
1993 [70] 
Multiple sclerosis: the 
relationship among self-
esteem, social support, and 
coping behavior. 
101 WCC Self-esteem was positively related 
to problem-focused coping. No 
relation between social support and 
problem-focused coping. 
Wineman NM 
1994 [58] 
A comparative analysis of 
coping behaviors in persons 
with MS or spinal cord 
injury. 
433 MS 
257 SCI 
WCC-R No differences between the groups. 
Subjects used more emotional 
coping at high illness uncertainty 
and more problem-focused coping 
at no uncertainty. 
Mohr DC 
1997 [30] 
Depression, coping and 
level of neurological 
impairment in MS. 
101 WCI Patients with advanced impairment 
have increased risk for depression 
and depression and advanced 
impairment are associated with 
maladaptive coping. 
Pakenham KI 
1997 [71] 
The role of coping in 
adjustment to MS-related 
adaptive demands. 
134 WCC Reliance on emotion-focused 
coping was related to poorer 
adjustment. In particular, avoidance 
was related to poorer adjustment. 
WCC Ways of coping checklist (Folkman and Lazarus 1988), Jalowiec Coping Scale (Jalowiec 1989), WCC-R Ways of 
coping checklist-Reviced, WCI Ways of coping inventory (Folkman & Lazarus 1985).
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I Cross-sectional studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
Jean VM 
1997 [72] 
Coping with general and 
disease-related stressors by 
patients with MS: 
relationship to 
psychological distress. 
75 MS 
26 HC 
WCC Patients reported higher levels of 
distress than controls, but similar 
patterns of coping. 
Beatty WW 
1998 [1] 
Correlates of coping styles 
in patients with MS. 
43 WCC Patients with higher level of 
psychological distress are likely to 
use emotion-focused coping 
strategies. 
Jean VM 
1999 [73] 
Psychological and 
neuropsychological 
predictors of coping by 
patients with MS. 
56 WCC Higher levels of distress were 
associated with emotion-focused 
coping and reduced effectiveness of 
the strategies employed. 
Kroencke DC 
1999 [74] 
Stress and coping in MS: 
exacerbations, remission 
and chronic subgroups. 
61 WOC Patients in current exacerbations 
had more hassles and they were met 
by more passive avoidance or 
aggressive coping. 
Mohr DC 
1999 [75] 
The psychosocial impact of 
MS: Exploring the patient’s 
perspective.  
94 WOCQ Benefit-finding (deepening of 
relationship, enhanced appreciation 
of life, spiritual interest) were 
related to positive reappraisal and 
seeking social support. 
deRidder D 
2000 [76] 
The relative benefits of 
being optimistic: Optimism 
as a coping resource in MS 
and Parkinson’s disease 
(PD). 
96 MS 
70 PD 
CISS Optimism has a disease-specific 
effect on physical adjustment and 
the use of emotion-focused and 
avoidance coping strategies. 
WCC Ways of coping checklist (Folkman and Lazarus 1988), WOC Ways of coping (Folkman & Lazarus1985), WOCQ
Ways of coping questionnaire (Scherer et al 1988), CISS Coping inventory for stressful situations (Endler & Parker 1994). 
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I Cross-sectional studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
Rätsep T 
2000 [77] 
Personality as a predictor of 
coping efforts in patients 
with MS. 
49 MS 
49 HC 
The COPE 
scale 
Relationship between personality 
traits and coping efforts in the 
patient group were different from 
control group. 
Lynch SG 
2001 [31] 
The relationship between 
disability and depression in 
MS: the role of uncertainty, 
coping and hope. 
188 WOC Depression was correlated with 
emotion-focused and not problem-
focused coping. 
Pakenham KI 
2001 [78] 
Coping with MS: 
development of a measure. 
414 
113 
CMSS 
WCC 
Passive avoidant and emotion-
focused coping are linked to poorer 
adjustment and problem-focused 
with better. 
Arnett PA 
2002 [79] 
Relationship between 
coping, cognitive 
dysfunction and depression 
in MS. 
55 The COPE 
scale 
Cognitive dysfunction was 
associated with depression when 
high levels of avoidance and low 
levels of active coping were 
employed. 
McCabe M 
2002 [80] 
Relationship functioning 
and sexuality among people 
with MS. 
381 MS 
291 HC 
WOCQ Coping and cognitive functioning 
were predictors of sexual 
functioning among women with MS. 
McCabe M 
2004 [81] 
Coping and psychological 
adjustment among people 
with MS. 
381 MS 
291 HC 
WOCQ People with MS are less likely to 
adopt problem-focused coping. 
Coping is associated with 
psychological adjustment. 
The COPE scale (Carver et al 1989), WOC Ways of coping (Folkman & Lazarus1985), CMSS Coping with MS scale 
(Pakenham 2001), WCC Ways of coping checklist (Folkman and Lazarus 1988), WOCQ Ways of coping questionnaire 
(Scherer et al 1988).
33
I Cross-sectional studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
Chalk HM 
2007 [82] 
Mind over matter: 
Cognitive-behavioral 
determinants of emotional 
distress in MS patients. 
329 CMSS Problem-solving coping was 
associated with positive 
psychological adjustment. Disease 
severity was not associated with 
adjustment. 
Montel SR 
2007 [83] 
Coping and quality of life in 
one hundred and thirty five 
subjects with MS. 
135 WCC 
CHIP 
SPMS tend to use more emotional 
coping while PPMS use more 
instrumental coping. 
Twork S 
2007 [84] 
Chronical illness and 
maternity: life conditions, 
quality of life and coping in 
women with MS. 
482 MS 
mothers 
607 
childless 
FKV-LIS Several differences in  QOL and 
coping between mothers and 
childless with MS. Mothers 
employed coping strategy 
religiosity/searching for sense in 
life. 
Haase CG 
2008 [85] 
Neuropsychological deficits 
but not coping strategies are 
related to physical disability 
in MS. 
48 MS 
women 
38 HC 
women 
FPI Increased depression scores and 
increased cognitive deficit in 
advanced physically disabled 
patients without selection of specific 
coping strategies. 
Kehler MD 
2009 [86] 
Is health anxiety a 
significant problem for 
individuals with MS? 
246 WOCQ Health and generalized anxiety were 
associated with emotional coping. 
Health anxiety was associated with 
problem-focused coping. 
Goretti B 
2009 [87] 
Coping strategies, 
psychological variables and 
their relationship with 
quality of life in MS. 
104 MS 
457 HC 
COPE-
NVI 
Patients were less likely to use 
problem-focused coping, avoidance 
were more frequent. Active coping 
strategies had positive influence on 
QoL. 
CMSS Coping with MS scale (Pakenham 2001), WCC Ways of coping checklist (Folkman and Lazarus 1988), CHIP
Coping with health, injuries and problems scale (Vitaliano et al 1985), FKV-LIS The Freiburg Questionnaire on Coping 
with Illness (Muthny 1989) ), FPI Freiburg’s coping questionnaire (Muthny 1992), WOCQ Ways of coping questionnaire 
(Scherer et al 1988) COPE-NVI coping orientation for problem experiences-new Italian version. 
34
II Longitudinal studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
Wineman NM 
1996 [88] 
Relationships among illness 
uncertainty, stress, coping, 
and emotional well-being at 
entry into a clinical drug 
trial. 
59 Jalowiec 
Coping 
Scale 
Patients entering drug trial with high 
levels of stress and uncertainty are 
likely to experience mood 
disturbances. 
Aikens JE 
1997 [89] 
A replicated prospective 
investigation of life stress, 
coping, and depressive 
symptoms in MS. 
27 WOCQ-R MS-related depressive symptoms 
are a function of prior disease-
related impairment, life stress and 
possibly escape avoidance coping. 
Pakenham KI 
1999 [90] 
Adjustment to MS: 
Application of a stress and 
coping model 
122 (96) WCC Better adjustment at T2 was related 
to less disability, greater reliance on 
problem-focused coping and less on 
emotion-focused coping. 
Mohr DC 
2002 [91] 
Moderating effects of 
coping on the relationship 
between stress and the 
development of new brain 
lesions in MS. 
36 CHIP Some findings support that coping 
moderates the relationship between 
stress and development of new brain 
lesions. 
Wineman NM 
2003 [92] 
Longitudinal analysis of 
illness uncertainty, coping, 
hopefulness, and mood 
during participation in a 
clinical drug trial. 
52 Jalowiec 
Coping 
Scale 
Coping effectiveness predicted 
hopefulness but not mood.  
Jalowiec Coping Scale (Jalowiec 1989),WOCQ-R Ways of coping questionnaire-revised (Folkman and Lazarus 1985), 
WCC Ways of coping checklist (Folkman and Lazarus 1988), CHIP Coping with health, injuries and problems scale 
(Vitaliano et al 1985). 
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II Longitudinal studies comparing groups and factors influencing coping. 
Author Title Sample Measure Key findings 
McCabe M 
2005 [93] 
Mood and self-esteem of 
persons with MS following 
an exacerbation. 
243 MS 
184 HC 
WOCQ Coping strategies did not predict 
mood. 
McCabe M 
2006 [94] 
A longitudinal study of 
coping strategies and QOL 
among people with MS. 
321 MS 
239 HC 
WOCQ Social support, focusing on the 
positive and wishful thinking were 
predictors of QOL. 
Pakenham KI 
2006 [95] 
Investigation of coping 
antecedents to positive 
outcomes and distress in 
MS. 
502 
(404) 
CMSS Coping predicted positive outcome 
at time 2 were emotional release, 
personal health control and physical 
assistance. Avoidance predicted 
distress. Acceptance predicted both. 
Arnett PA 
2006 [96] 
Longitudinal course of 
depression symptoms in 
MS. 
53 The COPE 
scale  
Decreased use of active coping may 
increase the risk for depressed mood 
and increased active coping could 
decrease depressive symptoms. 
Moreau T 
2008 [97] 
Coping strategy and anxiety 
evolution in MS patients 
initiating Interferon-Beta 
treatment. 
255 CISS In recently diagnosed RRMS 
patients, coping strategy as 
determined by CISS, impacted the 
level of anxiety and its evolution 
during the first months of IFN-
treatment. 
McCabe M 
2009 [98] 
Changes in quality of life 
and coping among people 
with MS over a 2 year 
period. 
382 MS 
291 HC 
WOCQ T1 patients had lower QOL and 
coping score than HC. After 2 years 
patients had increases in QOL and 
social/emotional support coping. 
WOCQ Ways of coping questionnaire (Scherer et al 1988) ), CMSS Coping with MS scale (Pakenham 2001), The COPE 
scale (52) (Carver et al 1989), CISS Coping inventory for stressful situations (Endler & Parker 1994).
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III Studies on different interventions using coping as outcome measure. 
Author Title Sample Measure Key findings 
Schwartz CE 
1999 [99] 
Teaching coping skills 
enhances quality of life 
more than peer support: 
results of randomized trial 
with MS Patients. 
64 
68 
WCC Coping skills group yielded gains 
over time in psychosocial role 
performance, coping behavior and 
aspects of well-being. Peer support 
effective for those with affective 
problems. 
Tesar N 
2003 [100] 
Effects of psychological 
group therapy in patients 
with MS. 
29 FPI Therapy group with cognitive and 
behavioral strategies showed long-
term improvements in depressive 
stress coping style 
WCC Ways of coping checklist (Folkman and Lazarus 1988), FPI Freiburg’s coping questionnaire (Muthny 1992).  
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2. AIMS OF THE STUDY 
The overall aim of this study was to investigate coping in patients with newly 
diagnosed multiple sclerosis (MS) and the longitudinal development of coping in 
these patients. In addition, the objective of the study was to investigate the effect of 
information and depression on their coping and to study how disability pensioned 
patients with MS cope. To obtain this information we have: 
- examined coping styles in a population of recently diagnosed patients with MS  
and explored how the quality of the information by the time of diagnosis 
influence coping (Paper I) 
- examined coping styles in patients with recently diagnosed MS as compared to 
normal controls and explored the relationship between depressive symptoms 
and coping styles in patients and controls (Paper II) 
- examined how coping styles in patients with MS change during a 5-year period 
and how patients’ coping styles are associated with disability pension (Paper 
III) 
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3. METHODS 
3.1 Patients at baseline and follow-up 
Patients diagnosed with MS during the time period from January 1. 1998 to December 
31. 2000 in Hordaland and the southern part of Rogaland in south-western Norway 
were invited to participate. The patient files of the Departments of Neurology at 
Haukeland University Hospital and Stavanger University Hospital were searched and 
patients included were intended to represent an unselected group of newly diagnosed 
patients with MS. A total of 108 patients were identified. A population of about 
700 000 inhabitants lived in the study area by the time of study entry and the average 
annual incidence for MS was 5.06/100 000. This is comparable with the annual 
incidence of Hordaland County observed by Grytten et al from 1993 to 1997 [4]. By 
the time of study entry one patient had died and two patients had moved out of the 
area. Of the remaining patients, 93 agreed to participate in the study. They all met the 
Poser criteria of definite or probable MS. 
Patients included had been followed regularly at the hospitals and were invited by 
letter to a 5-year follow-up. A total of 83 patients attended the follow-up visit. 
Reasons for not participating in the study were moved out of the study area (n=5), 
withdrawal of consent (n=4) and death (n=1). Of these remaining patients 76 
completed the COPE scale both at baseline and at the 5-year follow-up. 
3.2 Normal controls 
Two-hundred and twenty age, gender, geography matched and randomly chosen 
controls were selected by the National Population Registry. Ninety-six gave their 
informed consent to participate.  
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3.3 Assessment of disability 
Disability was assessed by Kurtzke’s Expanded Disability Status Scale (EDSS). 
EDSS is  the most commonly used scale in MS research, is neurologist-rated and rates 
disability caused by MS on a continuum of 0 (no impairment) to 10 (death due to 
MS). The scale includes pyramidal function, cerebellar function, brainstem function, 
sensory function, bladder/bowel function, visual function and mental function [101]. 
3.4 Assessment of coping 
The COPE scale was developed by Carver, Scheier and Weintraub in 1989 as a result 
of a critical survey of the existing coping measures among those the most widely used 
scale, Lasarus and Folkmans ‘The ways of coping checklist’. Carver el al discovered a 
lack of focus and an ambiguity in some of the coping items and that the scales were 
empirically and not theoretically based [53]. After several revisions in its 
development, the scale was tested in a sample of 978 students. The final version 
contained 13 scales with 4 items each [102]. Later the authors have added two 
additional scales and in this study we have used the version with 15 scales and 60 
items. 
The first five scales are subdimensions of problem-focused coping: 
- Active coping: taking active steps to try to remove stressor. Example of item: 
‘I do what has to be done, one step at the time’. 
- Planning: thinking about how to cope with the stressor. Example of item: ‘I 
make a plan of action’. 
- Suppression of competing actions: putting other projects aside in order to deal 
with the stressor. Example of item: ‘I keep myself from getting distracted by 
other thoughts or activities’. 
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- Restraint coping: waiting until an opportunity to act presents itself. Example of 
item: ‘I force myself to wait for the right time to do something.’ 
- Seeking social support for instrumental reasons: seek advice, information and 
assistance. Example of item: ‘I ask people who have the same experience what 
they did’. 
The next five scales are subdimensions of emotion-focused coping: 
- Seeking social support for emotional reasons: get moral support, understanding 
and sympathy. Example of item: ‘I talk to someone about how I feel’. 
- Positive reinterpretation and growth: positive reappraisal that one may learn 
from. Example of item: I look for something good in what is happening’. 
- Acceptance: Example of item: ‘I learn to live with it’. 
- Turning to religion: Example of item: ‘I put my trust in God’. 
- Focus on and venting of emotions: to focus on distress and ventilate feelings. 
Example of item: ‘I get upset and let my emotions out’. 
The next three scales are subdemensions of avoidance coping: 
- Denial: Example of item: ‘I refuse to believe that it happened’. 
- Behavioral disengagement: Reduce and even give up the effort to deal with the 
stressor. Example of item: ‘I just give up trying to reach my goal’. 
- Mental disengagement: Distraction from thinking about the goal the stressor 
interferes with. Example of item: ‘I daydream about things other than this’. 
The last two scales are concerned with alcohol and humour: 
- Alcohol-drug disengagement: Example of item: ‘You drink alcohol or take 
drugs in order to think less about it’. 
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- Humour: Example of item: ‘You make jokes about it’.
The scales are theoretically based except for ‘positive reinterpretation and growth’, 
‘denial’, ‘acceptance’, ‘turning to religion’, ‘alcohol-disengagement’ and ‘humour’ 
that are empirically based. The questionnaire has a six-point Likert scale from 0=not 
at all to 5=a lot. For each subscale, a sum score is calculated and high sum scores 
indicate more use of that particular coping style [53].  
We selected the 9 scales believed to be the most relevant for patients with MS (3 
problem-focused, 3 emotion-focused and 3 avoidance strategies) partly to avoid 
multicolinearity because of the rather low number of participants and the high number 
of variables in the COPE scale. We removed the strategies active coping, suppression 
of competing activities and acceptance. They were corresponding to planning, 
restraint coping and positive reinterpretation and growth [53]. In addition, active 
coping and planning showed a strong association statistically. Statistical analysis 
exposed less diversity in the scores for restraint coping than for suppression of 
competing activities. The strategies turn to religion, alcohol-drug disengagement and 
humour were removed because of their skewed distribution. 
The COPE scale can be used in different formats. In the dispositional or trait-like 
version the respondents report the extent to which they usually do or feel when they 
are stressed. In the situational version respondents are asked to think about their most 
stressful situation in the last two months and then complete the ratings [53]. In our 
study we have used the dispositional version. First we asked the patients and the 
controls what they usually do or feel in general when they experienced stressful 
situations. Furthermore, we asked the patients what they usually do when 
experiencing stressful situations in connection with their disease. Finally, this last 
version was repeated at the 5-year follow-up. 
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3.5 Assessment of the quality of patient information 
For this study we developed an instrument to examine the quality of perceived 
information by the patients. The instrument is based on discussions with neurologists 
and patients about the content of the information by the time of diagnosis and relevant 
literature [15, 63, 103, 104]. The patients were asked to think about the situation when 
they were told they had MS and indicate how they experienced the information they 
were given at that time. The questionnaire contains four questions on the content of 
the information:
'Was the information about the disease MS satisfactory?  
'Did they inform you about the treatment for the disease?'  
'Did you get information about how to handle your job, family and friends?'  
'Did you get information about what it implies to live with MS?’  
The response alternatives were 'yes', 'some', 'too little' and 'no'.  
In addition, the instrument consists of five statements about the experience of the 
information:  
'They gave me adequate information about MS',  
'I had time enough to think through what they told me and to ask questions',  
'They told me the consequences MS could have for my daily life',   
'They encouraged me to ask questions'  
'I felt cared for'.  
On these five statements the participants could indicate their degree of 
agreement/disagreement on a five point Likert scale; one indicating ‘fully agree' and 
five  'don't agree'. Based on the results from the 9 items on the questionnaire the 
patients' degree of satisfaction with the information was categorized into a scale from 
0 – 4. Individuals with scores 0 through 1 were categorized as ‘very dissatisfied’, 
more than 1 through 2 as ‘dissatisfied’, more than 2 through 3 as ‘satisfied’, and 
finally, more than 3 through 4 as ‘ very satisfied’. 
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Two patients with MS tested the questionnaire before study start. To test the 
dimensionality of the items from the quality of the information questionnaire factor, 
we conducted analysis implementing principal axis factoring and a minimum 
eigenvalue of 1. This analysis showed a one-factor solution, whereas a reliability 
analysis yielded a Cronbach’s alpha of 0.93. These results indicate that the scale on 
information quality is internally consistent and assesses a uniform concept.  
3.6 Assessment of depression 
The Beck Depression Inventory (BDI) is a self-rating scale for depression. 
Furthermore, it represents the gold standard for self-rating of depression [105] and is 
widely used in studies of patients with MS [106, 107].  It is a 21-item scale with a 
series of statements rated from 0 to 3, denoting increasing severity of symptoms. 
Patients were asked to select the one item that best describes the way they feel at the 
moment. Examples of items include feeling of sadness, concerns about the future, 
suicidal ideation, tearfulness, sleep, fatigue, interests, worries about health, sexual 
interest, appetite and general enjoyment. The scale has been validated and has shown 
excellent consistency [106]. We assessed patients and controls with the BDI both at 
baseline and at the 5-year follow-up. 
3.7 Assessment of cognition 
Cognition was measured by four instruments: 
- Paced Auditory Serial Addition Test (PASAT) is an operationalization of 
working memory where the score represents the number of correct answers 
[108].  
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- Symbol Digit Modality Test (SDMT) is to assess visual scanning and tracking 
aspects of attention and the amount of correct answers in 90 seconds make up 
the score [109].  
- Buschke Selective Reminding Test (SRT) is to measure verbal learning and 
memory that includes measures for Long Time Storage (SRT-LTS), Consistent 
Long Term Retrieval (SRT-CLTR) and Delayed Recall (SRT-DR) [110].  
- Kurtzke’s Functional Score (KFS) is the score for cerebral or mental function 
in EDSS and ranges from 0 (normal) to 5 (dementia or chronic brain syndrome 
– severe or incompetent) [101].   
3.8 Statistical analysis 
In study 1 the prevalence of general and MS-related coping styles were demonstrated 
with mean scores and standard deviations. In addition, we produced differential 
scores by subtracting the score for general coping from the score for MS-related 
coping, and by that we demonstrated to which degree the patients used the same 
coping styles for MS-related as for general stress situations. The dimensionality of the 
items from the quality of the information questionnaire factor was tested by principal 
factor analysis. Furthermore, we conducted reliability analysis to test the internal 
consistencies of the different scales used. A multivariate procedure, general linear 
modelling (GLM) was used to demonstrate the associations between quality of 
perceived information and MS-specific coping styles. 
In study 2 we analyzed differences in scores for depressive symptoms between the 
two sub-samples, patients and controls, by both an independent t-test and a Mann-
Whitney U test for non-normal distribution. Furthermore, we conducted analysis of 
correlations and partial correlations of scores for MS-specific coping styles with 
scores for depressive symptoms among the MS-sample and for general coping styles 
and depressive symptoms among the control sample. GLM was used to test 
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differences in mean scores between sub-samples in scores for general MS-coping in 
patients and general coping styles in controls. 
In study 3 we applied a Chi-squared test for testing differences in portions for 
categorical variables, Student’s t-test to compare means for continuous variables in 
two groups, and paired Student’s t-test to compare means for continuous variables at 
baseline and at five years. GLM was applied to compare means for continuous 
independent variables when comparing coping in two groups where the repeated 
measurements was accounted for. In addition, the GLM was applied when comparing 
coping strategies in the two groups of patients at baseline and patients at five years. 
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4. RESULTS 
Paper I
We found that 43.2% of the patients were dissatisfied or very dissatisfied with the 
information by the time of diagnosis. Furthermore, we found that MS-related coping 
styles were influenced by the individual’s general coping styles. In our patient sample 
the most frequently employed MS-related strategies were positive reinterpretation and 
growth, planning and restraint coping while denial was the most infrequently 
employed strategy. In addition, we showed that patients who were satisfied with the 
information about the diagnosis employed to a lesser extent avoidance coping and 
more actively both planned and sought information about the situation.  
Paper II
In this study we found that patients with MS employed significantly less the problem-
focused strategies planning, restraint coping and seeking social support for 
instrumental reasons compared to normal controls. Furthermore, compared to normal 
controls patients used less the emotion-focused strategies positive reinterpretation and 
growth and seeking social support for emotional reasons. The mean BDI scores for 
depressive symptoms were 10.9 in patients with MS and 4.7 in normal controls. In 
stress situations connected to MS, depressive symptoms was in these patients related 
to the problem-focused strategies of restraint coping and planning, the emotion-
focused strategy of focusing on and venting of emotions, and the avoidance strategies 
of behavioural- and mental disengagement and denial. The associations to depressive 
symptoms were similar for coping with stress situations in general, except for the 
coping strategy of planning that showed no relation to depressive symptoms. 
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Paper III
In MS patients who were followed throughout a 5-year study period, patients’ scores 
on problem- and emotion-focused strategies showed no significantly change but a 
trend (statistically non-significant) towards lower scores than at baseline and 
significantly lower as compared to general coping in normal controls. The results 
from baseline on avoidance coping did not change at the 5-year follow-up, and were 
similar as compared to normal controls at baseline. The portion of patients with 
disability pensioned increased from 51% at baseline to 73% at the 5-year follow-up 
and patients with disability pension had significantly higher age, more disability and 
depression and lower scores on three of six cognitive tests than those without. Patients 
who were disability pensioned also had significantly higher scores on the problem-
focused strategy seeking instrumental social support, emotion-focused strategy focus 
on and venting of emotion, and the avoidance strategy behavioural disengagement. 
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5. DISCUSSION 
To be diagnosed with a chronic, progressive disease without cure as a young or 
middle aged adult is to cope with high levels of stress. In the early stage with a 
disease, stress may be related to the uncertainty of the first symptoms and the 
recognition of having a serious disease that will affect the rest of your life. Later it 
becomes important to gain control over the influence that the disease have on one’s 
life and to cope with a set of ever-changing stressors. This process depend heavily on 
the individuals appraisal of the stress situation, their coping ability and their social 
network [41].  
5.1 General aspects of methodology 
When studying epidemiological features of a disease it is important that it is an 
unselected sample, correct diagnosis and that the instruments are well-tested and 
valid. 
The study population from southern Rogaland and Hordaland consisted of all patients 
who were diagnosed with MS in 1998, 1999 and 2000. The diagnosis of MS was 
established according to the Poser criteria and by experienced neurologists. Several 
prevalence and incidence studies have been performed in the Hordaland area [4, 6, 
111] and the annual incidence has been about 6.0 new patients pr 100.000 population 
during the last twenty years. In our study a total of 108 patients with MS were 
identified and approximately 700.000 inhabitants were living in the study area. This 
gives an average annual incidence of 5.1/100.000 and is comparable to previous 
findings. Study recourses did not allow the ideal door-to-door survey. However, MS 
patients in the two areas are referred to either Stavanger University Hospital or 
Haukeland University Hospital and to obtain an unselected group of patients, the files 
at the departments of Neurology were searched for MS-patients diagnosed from 1998 
to 2000. At baseline 93 of the 108 detected patients gave their consent to participate 
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in the study and 86 of these completed the COPE scale. The non-completers were not 
different from the participating patients in terms of demographic and clinical 
variables. We therefore believe that the majority of the patients in the study area were 
detected and that the cohort is representative for early MS populations in Western 
Norway. 
At the 5-year follow-up 83 patients with MS were included and 76 completed the 
COPE scale. Among the seven patients who failed to complete the COPE scale there 
were three patients who refused to participate and in four patients the consequences of 
the disease made it impossible for them to do so. 
After one reminder 96 (44%) of the 220 normal controls gave their consent to 
participate in the study. The rather low response rate affected only to a minor degree 
the gender and age distribution of the participating control group. Attrition is seldom 
totally random and the higher rate of attrition the greater likelihood of bias [112]. 
44% response rate is low and since we do not know much about the non-responders a 
possible bias should be of concern.  
Another important issue in studies like ours is to use appropriate measurement 
instruments. The COPE scale is a validated instrument that has been used to study 
coping with different health problems including MS [79, 96, 113].  The COPE scale 
reflects a balanced view of dispositional versus situational or time-limited coping and 
has been tested for both versions. In our first study, we compared the patients’ coping 
ability towards general stress situations and disease related stressors and found a 
strong correlation between the two. The same pattern of coping strategies as in our 
first study still exited after five years with the disease.  
The full COPE scale has 60 items and patients may become tired in completing the 
instrument because of its length [114]. The application of such a demanding 
instrument on a population who suffers from a relatively severe disease may be 
difficult. In addition, the COPE scale was one of many instruments that were applied. 
For further studies it would be wise to consider The Brief COPE with 28 items. 
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As there were no validated instruments to assess the quality of the information given 
to patients with MS, it was necessary to develop our own instrument. The instrument 
was based on interviews with MS-patients and clinicians and furthermore it was 
tested on a group of patients. Creating a new instrument is demanding because it is 
difficult to develop an accurate and valid scale, but we attempted to solve this by 
testing the instrument statistically. The results of the factor analysis indicate that the 
scale on information quality is internally consistent and assesses a uniform concept.  
BDI is the most commonly used depression scale and is considered as the best 
approach for screening depression in MS [115]. A cut-off score of 13 is 
recommended as optimal for screening depression and seems to screen for about 70% 
of MS patients [115, 116]. A problem with assessing depression in MS is the overlap 
between depression and  MS-related symptoms like fatigue, work problems and 
concerns about health [106]. This may result in an overestimation of depression. 
[117].  
In study I and II we have used a cross-sectional design and studied different 
characteristics of the patient population at one time point. The purpose was to 
determine associations between variables like the quality of the information and 
coping ability. The advantages of this design are that it is relatively economical and 
easy to perform. In study III we have applied a longitudinal design where new data 
were collected from the same population after five years. This design allows the 
researcher to identify change over time like coping styles after five years with MS. 
The challenge in this design is attrition over time. In our study the number of 
participants decreased from 86 to 76 after five years. Some of the drop-outs were too 
disabled to participate and this may bias the study population and decrease the  
generalizability of the findings [112]. 
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5.2 Is it possible to measure coping and does it make sense? 
Most of the research in MS has focused on the biology to understand the disease 
process with the purpose to find a treatment. In addition, the focus has been on 
treating symptoms or complications of the disease. However, the patients’ experience 
with MS will reflect both its biology and the psychological and social aspects of 
living with the disease. As there is no cure for MS, both patients and health personnel 
should focus on adaption to the disease and coping as an important mediator in that 
process.   
Gradually coping has been viewed as a normal, healthy and conscious process that 
enables people to deal with problems in their lives [50]. This was followed by the 
development of measurement instruments that should reflect the individuals’ effort to 
cope with stressful life events; an effort that were described as strategies and enabled 
researchers to conceptualize coping responses [51]. Research on coping were greatly 
stimulated by the development of The Ways of Coping Checklist in the 1970s and 
opened for studies on large groups of individuals. Furthermore, it became possible to 
quantify the coping process and this may be useful and important in understanding 
persons’ reactions towards stress situations in having a chronic disease and to develop 
strategies to help persons to a better living with the disease [54].  
There are, however, critiques of the research on stress and coping. The gap between 
the process and individualized theory of stress and coping and the methodology of 
coping research calls for a longitudinal, process-oriented research design. However, 
most studies are cross-sectional designs that may not capture this dynamic process 
[118, 119].  
Another criticism of coping research is confounding, that is the risk that measures of 
coping may contain other variables than intended. An example from our study is that 
we have discussed the risk for overlap between avoidance coping and depressive 
symptoms. However, confounding has always been a challenge for the measurement 
of psychological processes [54]. In the study of coping and depression in MS we have 
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used normal controls, comparable for age and sex, to compensate for this problem 
with confounding. 
Coping is a wide concept with different definitions and several conceptual problems 
and although analysis of coping has not yet developed a concept with clear answers, 
some of these issues are being clarified by further exploration of the concept. 
Despite the critics, we would claim that it is possible to measure coping, but to do so 
researchers have to be aware of the limitations. Measuring coping by self-reports and 
coping instruments is one way to learn more about the concept. Other research 
methods could bring an expanded understanding of the concept. 
Research on coping makes sense if it brings new or confirm existing knowledge that 
give patients a better life with MS. The experiences of two young women being 
diagnosed with MS and their stories on how they were left alone to sort out their lives 
after being informed about the disease were my inspiration for doing this study. What 
does a person think and do and what factors may influence in a situation like this? 
The results from this study indicate that coping theory and the COPE scale describe 
important issues regarding this stressful event.  
We first examined patients’ perceived quality of the information given at the time of 
diagnosis and the influence of this experience eventually had on patients’ coping 
styles. It has been shown that even several years after patients had their diagnostic 
consultation with a neurologist they remembered in detail what was said and their 
emotional reactions both during the consultation and afterwards. Patients describe that 
they are told “to go home and live with it”. This feeling of being abandoned and 
isolated may make it difficult to cope with the stress associated with the disease 
symptoms and everyday problems. Our study shows that with the traditional 
doctor/nurse approach to provide information about the diagnosis, the findings 
indicate that better perceived quality of the information may reduce inappropriate 
coping strategies like denial and enhance adaptional strategies like seeking social 
support. Denial is considered ineffective in the sense that it makes a person more 
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vulnerable, closes the mind to what could be threatening and may lead to loss of 
energy and even depression [50]. Searching for support, information and advice seem 
to be important in coming in terms with uncertainty caused either by the nature of the 
disease or by the health care system in its communication with patients. 
In the second study we explored coping in patients with MS compared to that of 
normal controls. As expected we found that patients employed less problem-focused 
strategies than controls. More surprisingly was the discovery that they also employ 
less emotion-focused strategies. Together with the low scores on avoidance, as 
compared to the scores for normal controls, this shows that MS patients as a group 
behave passive to disease related stress situations. Patients also had more depressive 
symptoms than controls, but these symptoms did not explain the differences in coping 
between patients and normal controls. These findings are partly in line with other 
studies and confirm that patients with MS have problems with coping in an early 
phase of the disease. We also know from other studies that this early phase is 
important for the patients and they experience both anxiety and helplessness and may 
be in need for assistance to handle both problems with the disease and other areas of 
life affected by the disease. These findings have a direct relevance for the 
management of patients with MS and should encourage health personnel to establish 
multidisciplinary teams that can help patients with the consequences MS may have for 
family, social life and work.
In a recent published study McCabe et al [98] has examined coping and quality of life 
in 382 people with MS and 291 normal controls. As in other studies their findings 
suggested that people with MS adapt to the disease over time by the fact that they 
have lower scores on problem-focused coping strategies and lower quality of life at 
baseline as compared to two years later. In our study we did not find this tendency for 
MS patients to adapt to the disease. Our findings showed a remarkable stability of 
applied coping with strategies that are considered as maladaptive. The patients 
continued their pattern of passive coping. The explanation for this is unclear. Perhaps 
the health care system in Norway does not stimulate patients to cope with MS. As this 
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group is in the early phase of the disease, the assumption could be that they choose to 
live as normal as possible and avoid to proceed with the adaptation of the disease. 
Another explanation could be fear for what the future will bring. Further, it seems 
important to avoid the stigma of having this disease.  
We also found that patients were depressed and we know that depression is not well 
treated in MS. Depression may influence coping and should therefore be detected and 
treated but depression could not, as mentioned above, explain the majority of 
inappropriate coping.  
In paper 3 we also studied characteristics of MS patients who had been disability 
pensioned. As in other studies the group of patients who were disability pensioned 
was older and had more functional and cognitive problems. Furthermore, the findings 
on coping were diverging and did not form a typical coping pattern for these patients 
and it is difficult to draw any conclusions about the association between disability 
pension and coping style in this study. However, an important finding was that 
compared to those who were still working, disability pensioned patients sought more 
social support, were more behavioural disengaged and had more focus on and venting 
of emotions. This may indicate that these patients had less drive and felt more 
dependent on others. 
In summary, we have found that these patients with MS do not employ what is 
assessed as adaptive coping strategies either at baseline or at the 5-year follow-up. 
Good and adequate information by the time of diagnosis seem to reduce ineffective 
coping and enhance adaptive coping. Patients with MS experience depressive 
symptoms, but depression does not explain their different coping pattern compared to 
normal controls.  
Based on our examinations we have been able to bring new and important information 
on coping in early MS. We have shown that available rating scales provide 
meaningful and valuable information on coping with MS in both cross-sectional and 
longitudinal studies. 
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6. CONCLUSIONS 
The aims of this thesis were to examine coping styles in patients with MS and the 
longitudinal development of coping in these patients. The instruments applied are 
self-reports and represent the subjective experience of the patients themselves. Our 
studies bring meaningful and important information on coping in patients with MS. 
In this thesis we have studied how patients with MS cope in the early phase of the 
disease and how the perceived quality of the information by the time of diagnosis may 
influence their further ability to cope with the disease. We have showed that MS-
patients cope differently from normal controls. In addition, patients have more 
depressive symptoms, but these symptoms do not explain the differences in coping 
between patients and controls. Furthermore, our study shows how this group of 
patients copes during a 5-year follow-up. Finally, we have examined characteristics of 
those patients who perceived disability pension and studied their ability to cope. 
How patients with MS cope has been studied previously. We do, however, extend this 
knowledge by providing information on patients’ coping style in the early phase of the 
disease and during a 5-year follow-up period. In addition, we have studied factors that 
may influence coping ability in patients with MS.  
6.1 Implications for practice 
Our study shows that patients with MS seem to employ coping strategies that are not 
optimal for the adaption to their disease. The explanations for this are probably 
multifactorial but our findings should stimulate health personnel to provide a better 
care for these patients. Our research strengthens the apprehension that patients with 
MS need more help to cope with difficult situations regarding their disease. A closer 
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follow-up by the neurologist and MS-nurse, involvement of a multidisciplinary team 
and teaching courses should be available for these patients. 
To achieve that the quality of the perceived information of patients with MS is 
improved, it is important that health personnel offer time, privacy and dialog. In 
addition, patients should be offered the possibility to bring a next of kin and oral 
information should be supplemented by written information designed for newly 
diagnosed patients.   
Depression should be detected and treated in patients with MS, since depressive 
symptoms seem to enhance non-adaptive coping strategies. 
Both health personnel and employers should have special focus on the possibilities for 
patients to keep on working even though they may need special equipment or 
assessment. 
6.2 Implications for further research 
Further studies should explore possible intervention to improve coping and the 
management of patients with MS.  
Future studies are needed to replicate and supplement our findings. Follow-up studies 
over a longer period of time and with more participants would to a greater extent 
determine the impact of coping as the disease progresses. 
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